Add to Favorites Newsroom RSS Share
Tampa, FL USA

Our News on Newswise

Moffitt Researchers Use Single-Cell Imaging and Mathematical Modeling to Determine Effective Drug Properties

Drug therapies that target a specific molecule have changed the way patients are treated for cancer and greatly improved survival rates. However, some patients do not respond to these therapies because the drug is not reaching the tumor cells...
13-Mar-2018 9:00 AM EDT Add to Favorites

Moffitt Researchers Identify New Target to Reduce Risk of Graft-Versus-Host Disease

Moffitt Cancer Center researchers are trying to identify new drug targets to reduce the risk of GVHD. Their new study, published in the Proceedings of the National Academy of Sciences, shows a drug that targets the protein JAK2 may reduce the risk...
5-Feb-2018 11:05 AM EST Add to Favorites

Moffitt Researchers Discover New Approach to Stimulate an Immune Response Against Tumor Cells

New drugs that activate the immune system to target cancer cells have improved the lives of many patients with cancer. However, immunotherapies are not effective in all patients, and the success of these therapies depends on individual patient...
30-Jan-2018 9:05 AM EST Add to Favorites

Rare Melanoma Type Highly Responsive to Immunotherapy

Desmoplastic melanoma is a rare subtype of melanoma that is commonly found on sun-exposed areas, such as the head and neck, and usually seen in older patients. Treatment is difficult because these tumors are often resistant to chemotherapy and lack...
10-Jan-2018 2:05 PM EST Add to Favorites

Men, If You Have HPV, Odds Are You Will Be Reinfected with the Same Type

Men infected with HPV16, the type responsible for most HPV-related cancers, are 20 times more likely to be reinfected with the same type of HPV after one year. That is according to a new study published this month in the Proceedings of the National...
14-Dec-2017 1:05 PM EST Add to Favorites

Moffitt Researchers Discover New Targets for Approved Cancer Drug

TAMPA, Fla. (Oct. 10, 2017) – Developing new drugs to treat cancer can be a painstaking process taking over a decade from start to Food and Drug Administration approval. Scientists are trying to develop innovative strategies to identify and test...
10-Oct-2017 11:00 AM EDT Add to Favorites

New Study Finds Improved Vaccine That Protects against Nine Types of HPV is Highly Effective

TAMPA, Fla. – Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations. The advent of human papillomavirus...
6-Sep-2017 1:05 PM EDT Add to Favorites

Moffitt Cancer Center & Cvergenx Partner to Personalize Radiation Therapy

Moffitt’s Radiation Oncology Department will utilize Cvergenx’s Genomic-Adjusted Radiation Dose (GARD) model.
9-Aug-2017 11:05 AM EDT Add to Favorites

see all news

Our Experts on Newswise


Moffitt Cancer Center HPV Expert Kicked Off EUROGIN Conference

Anna Giuliano, Ph.D., director of Moffitt Cancer Center’s Center for Infection Research in Cancer, delivered the opening keynote address at the 2017 European Research Organization on Genital Infection and Neoplasia (EUROGIN) International...
10-Oct-2017 10:05 AM EDT

see all experts

Our YouTube Videos

Chat now!